A tale of two antiviral targets - and the COVID-19 drugs that bind them
Nat Rev Drug Discov
.
2022 Jan;21(1):3-5.
doi: 10.1038/d41573-021-00202-8.
Author
Megan Cully
PMID:
34857884
DOI:
10.1038/d41573-021-00202-8
No abstract available
Publication types
News
MeSH terms
Antiviral Agents / therapeutic use*
COVID-19 / immunology
COVID-19 Drug Treatment*
Humans
SARS-CoV-2 / drug effects
SARS-CoV-2 / immunology
Vaccines / immunology
Substances
Antiviral Agents
Vaccines